32 results on '"Barbara, Borroni"'
Search Results
2. Protective association of HLA‐DRB1 *04 subtypes in neurodegenerative diseases implicates acetylated tau PHF6 sequences
3. Apathy in presymptomatic genetic frontotemporal dementia predicts cognitive decline and is driven by structural brain changes
4. A data‐driven disease progression model of fluid biomarkers in genetic FTD
5. A cognitive composite for genetic frontotemporal dementia: GENFI‐cog
6. Trajectory of apathy, cognition and neural correlates in the decades before symptoms in frontotemporal dementia
7. The impact of culture on neuropsychological performance: A global social cognition study across 12 countries
8. Serum NFL as a predictor of disease progression in dementia with Lewy bodies
9. Subtype and stage inference identifies distinct atrophy patterns in genetic frontotemporal dementia that MAP onto specific MAPT mutations
10. The Free Cued Selective Reminding Test detects episodic memory impairment in the presymptomatic period of familial frontotemporal dementia within the GENFI cohort
11. Modelling the cascade of biomarker changes in progranulin‐related frontotemporal dementia
12. O4-02-01: PHASE 2A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF THE HISTONE DEACETYLASE INHIBITOR (HDACI), FRM-0334, IN ASYMPTOMATIC CARRIERS OF, OR PATIENTS WITH FRONTOTEMPORAL LOBAR DEGENERATION (FTLD) DUE TO, PROGRANULIN GENE MUTATIONS
13. P1-380: EARLY REGIONAL HYPOMETABOLISM IN PRE-SYMPTOMATIC CARRIERS OF MAPT : A GENFI SUB-STUDY
14. [IC‐P‐079]: MULTIPLE DISTINCT ATROPHY PATTERNS FOUND IN GENETIC FRONTOTEMPORAL DEMENTIA USING SUBTYPE AND STAGE INFERENCE (SUSTAIN)
15. [IC‐03–04]: WHITE MATTER HYPERINTENSITIES IN GENETIC FRONTOTEMPORAL DEMENTIA: A GENFI STUDY
16. [P1–029]: IN GENETIC FRONTOTEMPORAL DEMENTIA, FUNCTIONAL NETWORK EFFICIENCY IS MAINTAINED UNTIL THE ONSET OF SYMPTOMS: EVIDENCE FOR FUNCTIONAL RESILIENCE TO STRUCTURAL CHANGE
17. [P2–222]: SENSITIVITY AND SPECIFICITY OF TRANSCRANIAL MAGNETIC STIMULATION FOR DIFFERENTIAL DIAGNOSIS OF ALZHEIMER's DISEASE AND FRONTOTEMPORAL DEMENTIA
18. [P4–189]: SYMPTOM ONSET IN GENETIC FRONTOTEMPORAL DEMENTIA
19. [O4–02–02]: POLY‐GP DIPEPTIDE REPEATS AND NEUROFILAMENT LIGHT CHAIN AS BIOMARKERS IN PRESYMPTOMATIC AND SYMPTOMATIC FRONTOTEMPORAL DEMENTIA CAUSED BY C9ORF72 REPEAT EXPANSIONS
20. [P1–437]: PRESYMPTOMATIC WHITE MATTER INTEGRITY LOSS IN FAMILIAL FRONTOTEMPORAL DEMENTIA IN THE GENETIC FRONTOTEMPORAL DEMENTIA INITIATIVE (GENFI) COHORT: A MULTI‐CENTRE, CROSS‐SECTIONAL, DIFFUSION TENSOR IMAGING STUDY
21. O4-03-06: LONGITUDINAL ASSOCIATION BETWEEN APATHY AND COGNITIVE DECLINE IN PRE- AND POST-SYMPTOMATIC GENETIC FRONTOTEMPORAL DEMENTIA
22. IC‐P‐054: Grey matter differences in genetic frontotemporal dementia: Results from the genfi study
23. O2‐01‐01: Grey matter differences in genetic frontotemporal dementia: Results from the genfi study
24. O3‐13‐06: Targeted re‐sequencing of sorl1 in early‐onset Alzheimer's dementia: The european early onset dementia consortium
25. P4‐074: ITALIAN NETWORK FOR AUTOSOMAL DOMINANT ALZHEIMER'S DISEASE AND FRONTOTEMPORAL LOBAR DEGENERATION (ITALIANDIAFN)
26. P3‐036: SAP97 DRIVES ADAM10 FROM GOLGI OUTPOSTS TO THE SYNAPSE THROUGH A PKC‐DEPENDENT PHOSPHORYLATION PROCESS
27. P2‐099: CSF P‐TAU181/TAU RATIO TO DISTINGUISH FTLD‐TDP FROM FTLD‐TAU
28. IC‐P‐002: DEMENTIA EXPERTS' PERCEIVED DIAGNOSTIC VALUE OF PET AMYLOID IMAGING
29. IC‐P‐069: ITALIAN NETWORK FOR AUTOSOMAL DOMINANT ALZHEIMER'S DISEASE AND FRONTOTEMPORAL LOBAR DEGENERATION (ITALIANDIAFN)
30. P1‐171: DEMENTIA EXPERTS' PERCEIVED DIAGNOSTIC VALUE OF PET AMYLOID IMAGING
31. P4‐148: Merging amyloid‐beta cascade and activity‐dependent plasticity in hippocampus: A possible role for ADAM10
32. P3–254: SAP97 scaffolding protein mediates alpha–secretase ADAM10 trafficking and directly promotes its activity both in vitro and in vivo
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.